Standout Papers

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>n... 1987 2026 2000 2013 9.2k
  1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene (1987)
    Dennis J. Slamon, Gary M. Clark et al. Science
  2. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer (2005)
    Frances A. Shepherd, José Rodrigues Pereira et al. New England Journal of Medicine
  3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (2007)
    Malcolm J. Moore, David Goldstein et al. Journal of Clinical Oncology
  4. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) (2005)
    Lisa M. McShane, Douglas G. Altman et al. JNCI Journal of the National Cancer Institute
  5. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer (1999)
    Jennet Harvey, Gary M. Clark et al. Journal of Clinical Oncology
  6. REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005)
    Lisa M. McShane, Douglas G. Altman et al. British Journal of Cancer
  7. Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer (2004)
    Román Pérez-Soler, Abraham Chachoua et al. Journal of Clinical Oncology
  8. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer (2002)
    S. Eva Singletary, Craig Allred et al. Journal of Clinical Oncology
  9. Prognostic Factors in Breast Cancer (2000)
    Patrick L. Fitzgibbons, David L. Page et al. Archives of Pathology & Laboratory Medicine
  10. Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer (1993)
    D. Craig Allred, Gary M. Clark et al. JNCI Journal of the National Cancer Institute
  11. REporting recommendations for tumor MARKer prognostic studies (REMARK) (2006)
    Lisa M. McShane, Douglas G. Altman et al. Breast Cancer Research and Treatment
  12. Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer (2003)
    C. Kent Osborne, V J Bardou et al. JNCI Journal of the National Cancer Institute
  13. Reporting Recommendations for Tumor Marker Prognostic Studies (2005)
    Lisa M. McShane, Douglas G. Altman et al. Journal of Clinical Oncology
  14. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome (2004)
    Grazia Arpino, V J Bardou et al. Breast Cancer Research
  15. Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases (2003)
    Valérie‐Jeanne Bardou, Grazia Arpino et al. Journal of Clinical Oncology
  16. HER-2/neu oncogene protein and prognosis in breast cancer. (1989)
    Amol Tandon, Gary M. Clark et al. Journal of Clinical Oncology
  17. Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry (1989)
    Gary M. Clark, Lynn G. Dressler et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 39 from Science/Nature 210 standout
Sub-graph 1 of 15

Citing Papers

The biology and management of non-small cell lung cancer
2018 StandoutNature
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
2017 StandoutScience
54 intermediate papers

Works of Gary M. Clark being referenced

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer
1993 Standout
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
1989 Standout
and 11 more

Author Peers

Author Last Decade Papers Cites
Gary M. Clark 27959 14287 13822 265 43.7k
Daniel F. Hayes 25941 20441 12718 407 45.3k
Larry Norton 29114 15708 13531 528 49.6k
Clifford A. Hudis 23054 13808 8120 509 38.8k
Eric P. Winer 35888 19716 10467 730 55.0k
José Baselga 25287 9567 19503 482 45.7k
Martine Piccart 26838 16098 12544 830 41.8k
Nancy E. Davidson 20153 12093 17415 396 40.3k
Louis Fehrenbacher 24845 7832 8769 156 35.2k
José Baselga 34173 9219 17049 270 48.4k
Dennis J. Slamon 44305 13629 23233 412 64.3k

All Works

Loading papers...

Rankless by CCL
2026